Alkermes plc. Operating Lease, Liability, Noncurrent
Alkermes plc. (ALKS) had Operating Lease, Liability, Noncurrent of $61.98 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-07-28
- 2026-06-30: Operating Lease, Liability, Noncurrent $61.98M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $63.75M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $63.25M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $64.97M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $61.98M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $63.75M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $63.25M 10-Q · filed 2026-07-28 | |
| 2025-09-30 | $64.97M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $66.22M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $67.81M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $69.37M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $71.03M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $72.53M 10-Q · filed 2024-07-24 | |
| 2024-03-31 | $74.10M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $75.71M 10-K · filed 2025-02-12 | |
| 2023-09-30 | $78.55M 10-Q · filed 2023-10-25 | |
| 2023-06-30 | $82.34M 10-Q · filed 2023-07-26 | |
| 2023-03-31 | $86.11M 10-Q · filed 2023-04-26 | |
| 2022-12-31 | $76.29M 10-K · filed 2024-02-21 | $89.83M 10-K · filed 2023-02-16 |
| 2022-09-30 | $95.73M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $99.83M 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $104.01M 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $104.16M 10-K · filed 2023-02-16 | |
| 2021-09-30 | $107.86M 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $111.66M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $115.50M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $119.46M 10-K · filed 2022-02-16 | |
| 2020-09-30 | $96.72M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $99.44M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $101.01M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $5.34M 10-K · filed 2021-02-11 | |
| 2019-09-30 | $6.66M 10-Q · filed 2019-10-23 | |
| 2019-06-30 | $8.86M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $11.02M 10-Q · filed 2019-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |